Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds.

antimicrobial chronic wounds liquid crystal nanoparticles photodynamic therapy

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
17 Jan 2023
Historique:
received: 07 12 2022
revised: 12 01 2023
accepted: 14 01 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

Cutaneous chronic wounds impose a silent pandemic that affects the lives of millions worldwide. The delayed healing process is usually complicated by opportunistic bacteria that infect wounds.

Identifiants

pubmed: 36839628
pii: pharmaceutics15020305
doi: 10.3390/pharmaceutics15020305
pmc: PMC9964009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Acta Biomater. 2021 Jul 1;128:420-434
pubmed: 33857695
Inorg Chem. 2012 Mar 19;51(6):3743-53
pubmed: 22372462
Pharmaceutics. 2022 Oct 06;14(10):
pubmed: 36297559
Biomater Res. 2018 Sep 26;22:25
pubmed: 30275968
Photodiagnosis Photodyn Ther. 2022 Dec;40:103118
pubmed: 36109003
ACS Infect Dis. 2022 Apr 8;8(4):841-854
pubmed: 35255215
Free Radic Biol Med. 2018 Sep;125:62-71
pubmed: 29550327
Burns. 2020 Sep;46(6):1381-1388
pubmed: 32305138
ACS Appl Mater Interfaces. 2021 Nov 17;13(45):53530-53540
pubmed: 34726885
J Wound Care. 2008 Aug;17(8):333-41
pubmed: 18754194
ACS Appl Mater Interfaces. 2020 Feb 5;12(5):5624-5632
pubmed: 31918542
Acta Derm Venereol. 2018 Jan 12;98(1):157-158
pubmed: 28880344
Inflamm Regen. 2022 Oct 4;42(1):40
pubmed: 36192814
J Control Release. 2022 Jun;346:300-316
pubmed: 35483636
BMC Microbiol. 2019 Aug 16;19(1):189
pubmed: 31419942
Nat Rev Microbiol. 2020 Oct;18(10):571-586
pubmed: 32533131
Mol Cell Proteomics. 2019 Jun;18(6):1036-1053
pubmed: 30850421
Int J Mol Sci. 2018 Jul 10;19(7):
pubmed: 29996558
Lasers Surg Med. 2013 Mar;45(3):175-85
pubmed: 23508377
J Int Med Res. 2009 Sep-Oct;37(5):1528-42
pubmed: 19930861
Photodiagnosis Photodyn Ther. 2020 Jun;30:101682
pubmed: 32032780
J Colloid Interface Sci. 2018 Jul 15;522:163-173
pubmed: 29601958
BMC Microbiol. 2012 Nov 13;12:259
pubmed: 23148795
Eur J Pharm Sci. 2022 Mar 1;170:106103
pubmed: 34936936
Pharmaceutics. 2021 Jun 29;13(7):
pubmed: 34209654
J Bacteriol. 2007 Nov;189(22):7961-7
pubmed: 17675387
Molecules. 2020 Nov 08;25(21):
pubmed: 33171665
Front Microbiol. 2018 Apr 03;9:598
pubmed: 29666612
Expert Rev Anti Infect Ther. 2015 May;13(5):605-13
pubmed: 25746414
Biochem Biophys Res Commun. 2013 Jan 18;430(3):918-25
pubmed: 23261430
J Invest Dermatol. 2009 Aug;129(8):2031-45
pubmed: 19212345
Langmuir. 2020 May 19;36(19):5385-5393
pubmed: 32338515
J Invest Dermatol. 2007 Aug;127(8):2048-57
pubmed: 17446900
Photochem Photobiol. 2014 Nov-Dec;90(6):1413-22
pubmed: 25185511
NPJ Biofilms Microbiomes. 2022 May 26;8(1):42
pubmed: 35618743
Ther Deliv. 2015;6(12):1347-64
pubmed: 26652281
Int Wound J. 2020 Apr;17(2):285-299
pubmed: 31724831
Small. 2021 Jun;17(24):e2100531
pubmed: 33978317
J Cell Physiol. 2019 Sep;234(9):14689-14708
pubmed: 30693517
Pharmaceuticals (Basel). 2021 Feb 09;14(2):
pubmed: 33572282
Int J Pharm. 2013 Sep 15;454(1):249-58
pubmed: 23834835
J Phys Chem B. 2022 Aug 18;126(32):6083-6094
pubmed: 35938784
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
J Mater Chem B. 2022 Apr 13;10(15):2781-2819
pubmed: 35315858
J Photochem Photobiol B. 2022 Jul;232:112474
pubmed: 35644068
Int J Pharm. 2019 Jul 20;566:329-341
pubmed: 31152793
Front Microbiol. 2018 May 11;9:917
pubmed: 29867828
Biomedicines. 2021 Sep 08;9(9):
pubmed: 34572368

Auteurs

Muhammed Awad (M)

Centre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.

Zlatko Kopecki (Z)

Future Industries Institute, STEM Academic Unit, University of South Australia, Mawson Lakes, SA 5095, Australia.

Timothy J Barnes (TJ)

Centre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.

Anthony Wignall (A)

Centre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.

Paul Joyce (P)

Centre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.

Nicky Thomas (N)

Centre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.

Clive A Prestidge (CA)

Centre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide, SA 5000, Australia.

Classifications MeSH